Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
challenging, rewarding, exciting, collaborative, meaningful
What do you like best about the leadership team?
Passion, Courage, Commitment, Intellect and Innovation
What is most positive about the culture and environment at your company?
fast paced, constantly challenged, celebrate victories
What is the best part about your compensation package?
base, bonus and equity with monthly vesting after year 1
What makes you most happy at work?
Moving the company, the science and the function forward every day. Putting patients first
What are some of the best things about your team?
We have each others backs and we actually care about each other as people. We also have diverse and complimentary skills.
Other Employee Reviews for Karyopharm Therapeutics
×